← Eichor
Condition: Genito Urinary Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Genito Urinary Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Phase 1 · 6 location(s) · Deciphera Pharmaceuticals, LLC · NCT06966024Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT03412877Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy
NA · 1 location(s) · St.Gallen University of Applied Sciences · NCT06464536Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT04354064Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04235777Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Phase 2 · 2 location(s) · British Columbia Cancer Agency · NCT04273061Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT07524114Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genit
Phase 3 · 2 location(s) · Regina Elena Cancer Institute · NCT06717711VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/Phase 3 · 1 location(s) · Ottawa Hospital Research Institute · NCT05920343Adaptive Radiotherapy for Genitourinary Cancers
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07324798Feasibility Study of CBCT for IGRT in Cancer Patients
NA · 4 location(s) · Varian, a Siemens Healthineers Company · NCT06681233Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT07447050Discharge Medication Use Post-Operatively in GU Cancer Patients
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT06795087Gender Related Coping and Survivorship for Genitourinary Cancers
Phase N/A · 2 location(s) · Johns Hopkins University · NCT05649306Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical
Phase N/A · 5 location(s) · RefleXion Medical · NCT05406167High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NA · 1 location(s) · Algemeen Ziekenhuis Maria Middelares · NCT06835426Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT06580002Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05300308Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer
Phase 2 · 1 location(s) · Queen Mary University of London · NCT04624399Genomic Investigation of Unusual Responders
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03740503Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Ca
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT04038619Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · 84 location(s) · Spanish Oncology Genito-Urinary Group · NCT06724159Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01174121Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382Personalized Treatment of Urogenital Cancers Depends on the Microbiome
NA · 1 location(s) · Zealand University Hospital · NCT03962920A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04923178Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
NA · 1 location(s) · City of Hope Medical Center · NCT05519878Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Phase N/A · 7 location(s) · University Health Network, Toronto · NCT02906943Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06041503
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.